REQUEST A DEMO
Total
USD $0.00
Search more companies

Shenzhen Neptunus Interlong Bio-Technique Company Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Professional, Scientific, and Technical Services
Full name: Shenzhen Neptunus Interlong Bio-Technique Company Limited Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Shenzhen Neptunus Interlong Bio-Technique Company Limited is a company in China, with a head office in Shenzhen. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on November 15, 1994. It currently has a total number of 1,444 (2023) employees. There was a net sales revenue drop of 1.98% reported in Shenzhen Neptunus Interlong Bio-Technique Company Limited’s latest financial highlights for Q2C2024. Over the same period, its total assets decreased by 0.35%. The net profit margin of Shenzhen Neptunus Interlong Bio-Technique Company Limited increased by 1.98% in 2024.

Legal Address
Suite 1702,Neptunus Yinhe Technology Mansion, 1 Keji Middle 3Rd Road, Maling Community, Yuehai Sub-District,Nanshan District
Shenzhen; Guangdong; Postal Code: 518000

Contact Details: Purchase the Shenzhen Neptunus Interlong Bio-Technique Company Limited report to view the information.

Website: http://www.interlong.com

Basic Information
Total Employees:
Purchase the Shenzhen Neptunus Interlong Bio-Technique Company Limited report to view the information.
Outstanding Shares:
Purchase the Shenzhen Neptunus Interlong Bio-Technique Company Limited report to view the information.
Registered Capital:
Purchase the Shenzhen Neptunus Interlong Bio-Technique Company Limited report to view the information.
Financial Auditors:
Purchase the Shenzhen Neptunus Interlong Bio-Technique Company Limited report to view the information.
Incorporation Date:
November 15, 1994
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
70.38%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Shenzhen Neptunus Changjian Pharmaceutical Company Limited
100%
Fuzhou Neptunus Fuyao Pharmaceutical Company Limited
80%
Company Performance
Financial values in the chart are available after Shenzhen Neptunus Interlong Bio-Technique Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-1.98%
Total operating revenue
-1.85%
Operating profit (EBIT)
45.42%
EBITDA
30.55%
Net Profit (Loss) for the Period
32.69%
Total assets
-0.35%
Total equity
2.03%
Operating Profit Margin (ROS)
3.02%
Net Profit Margin
1.98%
Return on Equity (ROE)
0.9%
Debt to Equity Ratio
0.54%
Quick Ratio
0.3%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?